toms were not aggressively sought and documented. The larger of these series also appear biased in that they included patients with mild illness. Douglas and Downs9 identified 54 patients with acute respiratory failure who required mechanical ventilation and PEEP of whom 43 (80%) survived; all survivors were asymptomatic at the time of hospital discharge. Of 15 patients evaluated for 1-30 months after ARDS by Yahav and colleagues'5 none had symptoms, although only 10 of the 15 (66%) required mechanical ventilation, and only seven of these (47%) needed PEEP to maintain oxygenation.
Data from more recent series using a more rigorous definition of ARDS and including a more severely affected patient population suggest that symptom free recovery is somewhat less likely (66% and 50% in the studies by Peters et al18 and Halevy et al,'9 respectively). Interpretation of the study by Halevy et al, as well as that by Lakshminarayan et aP0 in which 40% of the group was asymptomatic, is complicated by the high incidence of smoking in the two study populations, although only 1 1% of the patients had symptoms that could be related to smoking before ARDS. The most systematic evaluation of symptoms after ARDS was by Ghio and associates2' who found that 21 of 25 patients (84%) studied between 0 3 and 7 5 years after their episode were symptomatic; 55% of those questioned at longer than one year remained so. The most common complaints were cough (44%), sputum production (50%), and dyspnoea (50%). Although 29% of the entire population studied were smokers, smoking status had no association with symptoms. Interestingly, less than half of those with pulmonary complaints had abnormal pulmonary function test results. Conversely, those with abnormal pulmonary function were no more likely to be symptomatic than those with normal pulmonary function. Platypnoea and orthodeoxia that spontaneously resolved over several weeks have also been reported in one patient."
Patients who recover from ARDS are at high risk for upper airway injury that may occur during their recovery. Laryngotracheal stenosis is a well recognised consequence of prolonged intubation,22 and vocal cord dysfunction is also common. The only symptomatic patient in the study of 3) . Histologically these cysts were lined by bronchiolar or metaplastic squamous epithelium. Marked bronchiolectasis has also been described. 33 The airflow obstruction that occurs in some patients might have a similar pathophysiological explanation. These findings are 1401 20 in many ways similar to the severe bronchopulmonary dysplasia that occurs as a consequence of the infant respiratory distress syndrome.32 Bronchopulmonary dysplasia is usually seen in premature infants who require mechanical ventilation and high concentrations of oxygen for prolonged periods. In its most severe form it results in cyst formation, dilated terminal airways, air trapping,3435 and chronic airflow limitation in those who survive.343637
Because air trapping may be missed when lung volumes are measured by gas dilution techniques, plethysmographic determination is preferred when evaluating patients complaining of dyspnoea following ARDS.
GAS EXCHANGE
Reduced carbon monoxide transfer factor (TLCO) is the most common pulmonary function abnormality seen in patients recovering from ARDS. Soon after the acute episode 75-100% of patients will have abnormal values.'82' Although some of these patients improve during the first year, 40-80% of those studied had reductions that persisted even after one year.10141820212331 Fortunately, although chronic severe reductions of transfer factor may occur, the degree of abnormality observed is generally mild (fig 4) .
Most patients have normal resting arterial blood gas tensions after recovering from ARDS. Exercise, however, may reveal more subtle gas exchange abnormalities. Elliott and colleagues'0 found that 11 of 13 patients (85%) had an alveolar-to-arterial oxygen difference (A-aDo2) that was normal at rest (measured one month after ARDS) but increased in all seven of those who were exercised. In Dead space tends to decrease with exercise, although the degree of decrease is reduced over that generally found in normal subjects. After recovery, shunt fraction may be normal or only mildly elevated,9 "43 although one patient reported by Buchser et aP0 had a shunt fraction that remained elevated at 15% of the cardiac output more than one year after ARDS. The failure of TLCO to return to normal in most survivors of ARDS contrasts with the improvement in spirometric values and lung volumes in these patients. Low TLCO values together with persistent abnormalities in VD/ VT suggest that destruction or obstruction of the pulmonary vasculature may have occurred. There are abundant histological data to indicate that vascular loss does occur in the acute phase of ARDS. Bachofen and Weibel38 found striking reductions in the numbers of pulmonary capillaries seen in specimens obtained after the first 24 hours of ARDS. Extensive thrombosis of pulmonary arteries has also been shown by both antemortem and postmortem arteriography ( fig 5) .391 Snow et a14' estimated morphometrically that the density of precapillary arterioles was reduced by 50%. Extensive occlusion of the microvasculature by fibrin thrombi and non-thrombotic vascular obstruction caused by intimal proliferation and endothelial cell swelling is also seen in acute ARDS.40"2 Early vascular occlusion may correlate with the severity of ARDS and with survival from the acute event.39 In a study of six patients recovering from ARDS who underwent exercise testing, Buchser calculated a reduced pulmonary capillary blood volume.30 At this time a complete understanding of the causes of gas exchange abnormalities after ARDS is lacking. There are inadequate data available to conclude that finding these abnormalities in the immediate period after ARDS is predictive of long term pulmonary dysfunction.
Predictors of pulmonary dysfunction It is difficult to attach prognostic importance to demographic or other patient characteristics that are unrelated to the episode of ARDS. In most studies patient numbers are too small to draw conclusions regarding whether the event associated with ARDS is correlated with outcome.
Ghio and colleagues2" found no relationship between the precipitating cause and long term abnormalities of pulmonary function. Case reports have suggested that patients with ARDS caused by viral pneumonia may be predisposed to developing fibrosis and suffering long term functional abnormality. 43" Although several studies have suggested that older age predisposes to persistent abnormality of pulmonary function,9203" Ghio and associates2' also recently noted that patients younger than 20 had an increased risk of residual dysfunction.
The acute cellular response in ARDS is a neutrophilic alveolitis.45 Because cigarette smoking also increases the bronchoalveolar lavage neutrophil content,46 particularly in the setting of chronic bronchitis,47 smoking might be expected both to contribute to more severe acute disease and to worsen pulmonary function in survivors. Unfortunately this supposition is not supported by the available data. Elliott et a148 and Peters et al'8 found no significant differences in follow up measurements of TLC, FVC, FEV1 or TLco between smokers and non-smokers, although the maximum improvement in pulmonary function did seem to take longer in smokers.'8 Nosocomial bacterial pneumonia is common in ARDS and is associated with worse acute pulmonary function and The severity of ARDS is probably the only variable having prognostic importance for subsequent pulmonary dysfunction. Ghio et al,2' and Elliott et al,48 in studies of 41 and 16 survivors of ARDS respectively, reported that subsequent pulmonary function correlated with the degree of abnormality in thoracic compliance, pulmonary artery pressure, and shunt fraction measured during the first days of illness. Patients with chronic abnormalities of pulmonary function required longer mechanical ventilation and higher levels of PEEP. Peters et al'8 found that patients with increased pulmonary vascular resistance, pulmonary arterial pressures, and A-aDo2 measured on days 4-7 of their acute episode of ARDS had lower values of FVC, FEVy, and TLCO. The presence of barotrauma and the need for an Fio2 > 0-6 for longer than 24 hours has been associated with a reduced TLCO measured one year later.2' Two other small studies found no correlation between abnormalities of lung function and (1) the severity of ARDS, (2) the duration of mechanical ventilation,'5 (3) the duration of PEEP therapy, or (4) the initial arterial oxygen tension.3" Despite these contradictions most of the data support the association between the severity ofARDS and chronic pulmonary dysfunction.
Effect of management of ARDS on subsequent pulmonary function Care of patients with ARDS is often described as being "supportive" in that no specific treatment for the pathophysiological abnormalities -that is, acute lung inflammation -has been described. It is important to consider the possibility that some aspects of this support, in particular mechanical ventilation and hyperoxia, may actually contribute to the severity of the acute episode and therefore potentially affect the degree of pulmonary dysfunction in the survivors.
LUNG VOLUME AND POSITIVE END EXPIRATORY PRESSURE
Numerous studies in animals have shown that positive pressure ventilation at high inspiratory pressures causes acute lung injury.54 6 Two important studies showed that it is the large tidal volumes generated by the increased inspiratory pressure, rather than the high pressure itself, that is responsible for the injury. Hernandez et al6' compared the effects of ventilating two groups of rabbits with high peak inspiratory pressures. One group was placed in full body plaster casts and the second group was not. The injury produced by high peak inspiratory pressure in the control group (manifested as increased microvascular permeability) was completely prevented by the plaster cast which limited the end inspiratory volume. Dreyfuss and coworkers62 reported similar findings using chest strapping to control inspiratory volume.
The tidal volume required to cause lung injury in animals with otherwise normal lungs is generally higher than that used in clinical practice. Smaller tidal volumes can cause this type of damage in patients with ARDS because the lung inflammation, oedema and atelectasis are not homogeneously distributed. Accordingly, there are significant differences in local alveolar compliance such that areas of normal lung (that have normal compliance) will expand to a greater extent than areas that are injured (with lower compliances).6"' Although no well designed trials have investigated whether ventilating with low tidal volumes can reduce mortality or acute or long term morbidity in humans, a recent retrospective uncontrolled study suggests that this may be the case. Hickling and colleagues65 reported the results of 50 patients with severe ARDS who were ventilated with low tidal volumes. The partial pressure of arterial CO2 was allowed to rise to a mean of 60mm Hg. The mortality in these patients was only 16%, considerably better than other published results.56 Decreased mortality has also been reported using "permissive hypercapnia" in ventilated patients with status asthmaticus. 66 If tidal volume is kept constant, PEEP will increase peak and mean airway pressure as well as end inspiratory and end expiratory lung volumes. Accordingly, the level of PEEP can also cause or contribute to lung injury. Because the most severe cases of ARDS generally are treated with higher levels of PEEP to prevent hypoxaemia, it is difficult to distinguish between a deleterious effect of PEEP and the effects of ARDS itself.
Most experimental evidence argues that low levels of PEEP protect the lung from ventilator associated injury. Webb and Tierney first noted in animals that 5 cm H20 of PEEP reduced the amount of oedema caused by ventilation at high inflation pressures (and volumes).60 This protective effect has been supported by other investigators using models of both hydrostatic oedema67 and increased permeability oedema.6268 Although PEEP does not reduce lung water and may actually increase it,6971 it redistributes the oedema away from alveoli into the interstitium,72 and also prevents depletion of surfactant that results from lungs being ventilated at low end expiratory volumes.6'7'74
The level of PEEP has been shown by some to correlate inversely with long term pulmonary function.2'4 Elliott and coworkers reported that survivors of ARDS with abnormalities of lung function were more likely to have received higher levels of PEEP than those with normal function.23 In contrast, Peters et al'8 reported that higher levels of PEEP during the first week of ventilator support were associated with more normal values of TLC and FVC measured more than six months after the acute episode. Patient characteristics, predisposing conditions, and severity of disease do not seem to explain these differences.
Fio2
The level to which Fio2 must be raised to correct hypoxaemia is another marker for the severity of the acute episode. The effect of oxygen on the course of patients with ARDS is difficult to ascertain because those with the worst disease require the most intensive support. In addition, there is no histological difference between ARDS and oxygen toxicity.75 Ample animal data suggest that hyperoxia can create or worsen pulmonary injury.750 In animal models of oleic acid-induced acute lung injury, breathing 40%81 or 50%82 oxygen causes no additional lung injury while 100% oxygen results in progressive oedema and dysfunction.
There are obviously no studies examining the effects of chronic hyperoxia on normal subjects. Because there are considerable species variabilities with regard to susceptibility to oxygen toxicity," the relevance of animal studies to patients with ARDS is uncertain. In humans, Van de Water et al83 found no significant physiological differences between healthy individuals breathing 100% oxygen for 6-12 hours and those breathing air. Singer et al84 reported no 
